December 18, 2017 / 5:28 PM / 2 months ago

BRIEF-Oncodesign Updates on Results For Mutated Anti-EGFR Radiotracer

Dec 18 (Reuters) - ONCODESIGN SA:

* ONCODESIGN: PROMISING CLINICAL RESULTS FOR INNOVATIVE MUTATED ANTI-EGFR RADIOTRACER IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

* ‍FIRST STAGE OF PHASE 1 CLINICAL STUDY COMPLETED WITH PROMISING RESULTS​

* ‍LAUNCH OF SECOND STAGE TO EVALUATE SPECIFICITY OF RADIOTRACER​

* ‍FULL STUDY RESULTS EXPECTED IN H1 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below